Press Releases

As part of its Review of Operations, CannTrust reduces workforce and spend while preserving key talent VAUGHAN, ON, Sept. 5, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: 

ALHAMBRA, Calif., Sept. 5, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that its affiliates, Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of Califo

MEXICO CITY, Sept. 5, 2019 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced the placement of

Patients are advised to immediately consult their healthcare providers to help ensure safe discontinuation of NATPARA treatmentTakeda is working closely with the US Food and Drug Administration (US FDA) to resolve the issue and resume supply as soon as possible OSAKA, Japan, Sept. 5, 2019 /PRNewswire/ -- Takeda Pharmaceutical Company Limited

VANCOUVER, Sept. 5, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) is pleased to announce the appointment of Andy Bayfield as Chief Commercial Officer ("CCO"), effective September 3, 2019. Mr. Bayfield will be managing our sal

PISCATAWAY, N.J., Sept. 5, 2019 /PRNewswire/ -- Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approvals for their generic versions of Decitabine and Fosaprepitant for injection.  Decitabine was approved on August 29

SCOTTSDALE, Ariz., Sept. 5, 2019 /PRNewswire/ -- Healthcare Trust of America, Inc. ("HTA") (NYSE: HTA) announced today that its operating partnership, Healthcare Trust of America Holdings, LP ("HTALP" and, together with HTA, the "Company"), priced a $250 million offering of HTALP's 3.500% senior unsecured notes due 2026 (the "2026 Note

BRIDGEWATER, N.J., Sept. 5, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to six new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensa

TEXAS, Sept. 5, 2019 /PRNewswire/ -- For the second year in a row, Texas-based wellness brand, fitppl, has been named a

SAN DIEGO, Sept. 5, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the results of a pre-planned interim dosing analysis in the phase 2 CALDOSE-1 study of IMU-838